Literature DB >> 2194636

The role of activated T lymphocytes in gastrointestinal disease.

T T MacDonald1.   

Abstract

Activated T cells can be visualized in the intestinal lamina propria in a number of gastrointestinal diseases including food-sensitive enteropathy (coeliac disease), inflammatory bowel disease and intractable diarrhoea of infancy. Experimental studies have shown that T-cell activation in human intestinal lamina propria in vitro produces an increase in crypt cell proliferation, villous atrophy, increased HLA-DR expression on enterocytes, increased intra-epithelial lymphocyte numbers, and phenotypically, macrophage activation. All of these features are seen in human gastrointestinal disorders and it is proposed that T-cell activation to wheat (in coeliac disease), milk (cows' milk-sensitive enteropathy), and unidentified luminal antigens (Crohn's disease) plays a primary role in the pathogenesis of these disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194636     DOI: 10.1111/j.1365-2222.1990.tb02679.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  13 in total

1.  Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis.

Authors:  M A Pérez-Machado; L M Espinosa; E J de la Madrigal; L Abreu; G M Lorente; M Alvarez-Mon
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 2.  Mucosal T cell subsets in coeliac disease: expression of T cell receptor and CD45 isoforms.

Authors:  T S Halstensen; P Brandtzaeg
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells.

Authors:  M W Leach; A G Bean; S Mauze; R L Coffman; F Powrie
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

Review 4.  Old and New Lymphocyte Players in Inflammatory Bowel Disease.

Authors:  Paolo Giuffrida; Gino Roberto Corazza; Antonio Di Sabatino
Journal:  Dig Dis Sci       Date:  2017-12-23       Impact factor: 3.199

Review 5.  Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?

Authors:  M J Weldon; J D Maxwell
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

6.  Keratinocyte growth factor and coeliac disease.

Authors:  V M Salvati; M Bajaj-Elliott; R Poulsom; G Mazzarella; K E Lundin; E M Nilsen; R Troncone; T T MacDonald
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

Review 7.  The ontogeny of the gut mucosal immune system and the susceptibility to infections in infants of developing countries.

Authors:  G Prindull; M Ahmad
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

8.  Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.

Authors:  E Breese; C P Braegger; C J Corrigan; J A Walker-Smith; T T MacDonald
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

9.  In vitro human lymphocyte proliferative responses to a glycoprotein of the yeast Saccharomyces cerevisiae.

Authors:  C J Darroch; S E Christmas; R M Barnes
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

10.  Both Th1 and Th17 are immunopathogenic but differ in other key biological activities.

Authors:  Catherine A Cox; Guangpu Shi; Hongen Yin; Barbara P Vistica; Eric F Wawrousek; Chi-Chao Chan; Igal Gery
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.